Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Steroid 11-beta-hydroxylase

Inactivating mutations of this key enzyme in steroid hormone production cause hypertensive form of adrenal hyperplasia. A rare rearangement at this locus is found to be responsible for glucocorticoid remediable hypertension.

Genetests:

Clinic Method Carrier testing
Turnaround 5 days
Specimen type genomic DNA
Clinic Method Massive parallel sequencing
Turnaround 25 days
Specimen type genomic DNA
Clinic Method Genomic sequencing of the entire coding region
Turnaround 20 days
Specimen type genomic DNA
Clinic Method Multiplex Ligation-Dependent Probe Amplification
Turnaround 20 days
Specimen type genomic DNA

Related Diseases:

Hyperaldosteronism type 1
CYP11B1
CYP11B2

References:

1.

Lifton RP et al. (1992) A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

external link
2.

Mulatero P et al. (2004) Genetics of primary aldosteronism.

external link
3.

White PC et al. (1991) A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.

external link
4.

Orphanet article

Orphanet ID 120949 external link
5.

NCBI article

NCBI 1584 external link
6.

OMIM.ORG article

Omim 610613 external link
7.

Wikipedia article

Wikipedia EN (Steroid_11β-hydroxylase) external link
Update: Aug. 14, 2020
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues